Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease.

Ethane is a product of lipid peroxidation and can be measured in the exhaled air as an index of oxidative stress. Oxidant/antioxidant imbalance is important in the pathogenesis of chronic obstructive pulmonary disease (COPD). Therefore, we measured exhaled ethane in 22 patients with COPD (mean age +/- SEM, 59 +/- 8 yr; 19 male) and compared it with other noninvasive markers of oxidative stress and inflammation such as carbon monoxide (CO), measured electrochemically, and nitric oxide (NO), measured by chemiluminescence. Exhaled ethane was collected during a flow and pressure-controlled exhalation into a reservoir, discarding dead space air contaminated with ambient air. A sample of the collected expired air was analyzed by chromatography. Compared with normal subjects (n = 14; eight men; age, 33 +/- 2.8 yr), patients with COPD not on steroid treatment (n = 12; FEV(1), 58 +/- 6%) had elevated levels of exhaled ethane (2.77 +/- 0.25 and 0.88 +/- 0.09 ppb, respectively, p < 0.05), CO (5.96 +/- 0.50 and 2.8 +/- 0.25 ppm, p < 0.05) and NO (11.86 +/- 0.53 and 6.77 +/- 0.50 ppb, p < 0.05) levels. Ethane was correlated to FEV(1) (r = -0.67, p < 0.05). Patients receiving steroid treatment (n = 10; FEV(1), 56 +/- 2%) had lower levels of ethane (0.48 +/- 0.05 ppb) than did steroid-treated patients, whereas CO (5.99 +/- 0.63 ppm) and NO (9.11 +/- 0.53 ppb) levels were similar in the two treatment groups. Exhaled ethane is elevated, correlates with FEV(1), and is significantly lower in patients treated with steroids, so it may be complementary to the use of NO and CO in assessing and monitoring oxidative stress in COPD.

[1]  D. Postma,et al.  Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease , 1999, Thorax.

[2]  H. Boushey.  Glucocorticoid therapy for chronic obstructive pulmonary disease. , 1999, The New England journal of medicine.

[3]  H. Garewal,et al.  Effect of vitamin E on exhaled ethane in cigarette smokers. , 1999, Chest.

[4]  W. MacNee,et al.  Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. , 1999, American journal of respiratory and critical care medicine.

[5]  S. Fukuyama,et al.  Effect of Inhaled Glucocorticoid on the Cellular Profile and Cytokine Levels in Induced Sputum from Asthmatic Patients , 1999, Lung.

[6]  I. Horváth,et al.  Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. , 1999, The European respiratory journal.

[7]  G. FitzGerald,et al.  Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. , 1998, American journal of respiratory and critical care medicine.

[8]  R. Busse,et al.  Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. , 1998, Hypertension.

[9]  F. Hargreave,et al.  Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. , 1998, American journal of respiratory and critical care medicine.

[10]  Kanazawa,et al.  Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  N. Ambrosino,et al.  Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease , 1998, Thorax.

[12]  P. Barnes,et al.  Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis , 1998, Thorax.

[13]  P. Barnes,et al.  Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress , 1998, Thorax.

[14]  W. Maziak,et al.  Exhaled nitric oxide in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[15]  H Sasaki,et al.  Increased carbon monoxide in exhaled air of asthmatic patients. , 1997, American journal of respiratory and critical care medicine.

[16]  A Bast,et al.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.

[17]  P. Barnes,et al.  Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. , 1997, The European respiratory journal.

[18]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[19]  W. MacNee,et al.  Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.

[20]  A. Choi,et al.  Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. , 1996, American journal of respiratory cell and molecular biology.

[21]  J. Crapo,et al.  Generation and disposal of reactive oxygen metabolites in the lung. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[22]  J. Morrow,et al.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.

[23]  H. Garewal,et al.  Cigarette smoking and ethane exhalation in humans. , 1995, American journal of respiratory and critical care medicine.

[24]  C. Kneepkens,et al.  The potential of the hydrocarbon breath test as a measure of lipid peroxidation. , 1994, Free radical biology & medicine.

[25]  C. Nathan,et al.  Regulation of biosynthesis of nitric oxide. , 1994, The Journal of biological chemistry.

[26]  E. Weitzberg,et al.  Increased amount of nitric oxide in exhaled air of asthmatics. , 1993, The European respiratory journal.

[27]  T. Risby,et al.  Breath ethane: a specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liver. , 1992, Free radical biology & medicine.

[28]  P. Barnes,et al.  Reactive oxygen species and airway inflammation. , 1990, Free radical biology & medicine.

[29]  M. Habib,et al.  Source of ethane in expirate of rats ventilated with 100% oxygen. , 1989, Journal of applied physiology.

[30]  E. Zarling,et al.  Technique for gas-chromatographic measurement of volatile alkanes from single-breath samples. , 1987, Clinical chemistry.

[31]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[32]  J. Hoidal,et al.  Alterations in leukocyte oxidative metabolism in cigarette smokers. , 2015, The American review of respiratory disease.

[33]  I. Aulik.  [Gas chromatographic analysis of exhaled air and acetylene mixture]. , 1966, Biulleten' eksperimental'noi biologii i meditsiny.